The European Bank for Reconstruction and Development (EBRD) said it approved a €15 million loan to co-finance Ukrainian pharmaceuticals manufacturer Yuria Pharm Group's investment program in Uzbekistan, Ukraine and Latvia for 2025-2027.
The funding, focused on green projects and other capex, will be divided into €13 million committed and €2 million uncommitted tranches, both with a six-year tenor, according to the EBRD.
